Resposta cardiometabólica em pacientes pré-transplante cardíaco após terapia com sacubitril-valsartana

Borges, Lucas Martins Frizzera; Hossri, Carlos Alberto Cordeiro; Ferreira, Ana Luiza Guimarães; Crizóstomo, Ulissis Delgado; Ferraz, Almir Sergio; Rossi, João Manuel; Morais, Flávia Bernardes; Grecca, Guacira; Felicioni, Sandro Pinelli; Santos, Carolina Casadei dos; Mizzaci, Carolina Christianini; Buchler, Rica Dodo Delmar.
Arq. bras. cardiol ; 113(2 supl.1): 251-251, set., 2019.
Artigo Português | SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: biblio-1021277

Documentos relacionados

  1. Análise cardiometabólica de cardiopatas pré-transplante cardíaco após terapia com sacubitril-valsartana
  2. Maximal Oxygen Uptake and Ventilation Improvement Following Sacubitril-Valsartan Therapy.
  3. The Efficacy and Safety of Sacubitril-Valsartan for the Treatment of Heart Failure in Adults: A Meta-Analysis.
  4. Sacubitril/valsartan reduces endoplasmic reticulum stress in a rat model of doxorubicin-induced cardiotoxicity.
  5. proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action.
  6. Sacubitril/Valsartan Improves Left Ventricular Function in Chronic Pressure Overload Independent of Intact Cyclic Guanosine Monophosphate-dependent Protein Kinase I Alpha Signaling.
  7. Effect on the Quality of Life of Patients with Heart Failure and Reduced/Preserved Ejection Fraction Using Sacubitril/Valsartan.
  8. Cardiopulmonary exercise test-based assessment of the effects of sacubitril/valsartan on the blood pressure response to exercise in patients with acute myocardial infarction during hospitalization.
  9. Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.
  10. Effects of Sacubitril-Valsartan in Patients With Various Types of Heart Failure: A Meta-analysis.